Rather, these latter tumors retained high BCL2 expression in Ki67+ proliferating cells [103], which in both aggressive FL and DLBCL is explained by BCL2 gene translocation to the Ig heavy chain locus [104]. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.